Internal Medicine, Endocrinology, Diabetes, & Metabolism · American Fork, UT
NPI
1730507625
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1175 E 50 S Ste 241
American Fork, UT, 84003
Phone (801) 429-8008
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
1,772 services
Medicare patients, 2024
196
Average age 73
Drug cost, 2024
$1.0M
1,947 prescriptions
Company payments, 2025
$2,898
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohamed Dafalla was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 401 times for 189 patients. In total Mohamed Dafalla billed 1,772 services in 46 codes, and Medicare paid $54K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 401 | 189 | $11.27 | $4,519 |
| 99214 Office E&M - Established | Office | 326 | 152 | $85.14 | $28K |
| 36415 Venipuncture Blood Collection | Office | 166 | 118 | $8.65 | $1,436 |
| 95251 Test - Miscellaneous | Office | 140 | 53 | $24.39 | $3,414 |
| 83036 Blood Count | Office | 106 | 64 | $9.34 | $990 |
| 80053 Clinical Chemistry | Office | 96 | 85 | $10.35 | $994 |
| 84439 Clinical Chemistry | Office | 94 | 66 | $8.84 | $831 |
| 84443 Clinical Chemistry | Office | 94 | 66 | $16.46 | $1,547 |
| 99204 Office E&M - New | Office | 73 | 73 | $108.38 | $7,911 |
| 82570 Clinical Chemistry | Office | 51 | 48 | $5.08 | $259 |
| 82043 Clinical Chemistry | Office | 43 | 40 | $5.66 | $243 |
| 82306 Clinical Chemistry | Office | 30 | 29 | $29.01 | $870 |
| 84480 Clinical Chemistry | Office | 20 | 14 | $13.90 | $278 |
| 80061 Clinical Chemistry | Office | 18 | 18 | $13.12 | $236 |
| 85027 Blood Count | Office | 11 | 11 | $6.34 | $69.74 |
By year: 2022 $25K for 501 services; 2023 $43K for 1,110 services; 2024 $54K for 1,772 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 166 | 118 | $8.65 | $1,436 |
| 83036 Blood Count | 106 | 64 | $9.34 | $990 |
| 80053 Clinical Chemistry | 96 | 85 | $10.35 | $994 |
| 84443 Clinical Chemistry | 94 | 66 | $16.46 | $1,547 |
| 84439 Clinical Chemistry | 94 | 66 | $8.84 | $831 |
| 82570 Clinical Chemistry | 51 | 48 | $5.08 | $259 |
| 82043 Clinical Chemistry | 43 | 40 | $5.66 | $243 |
| 82306 Clinical Chemistry | 30 | 29 | $29.01 | $870 |
| 84480 Clinical Chemistry | 20 | 14 | $13.90 | $278 |
| 80061 Clinical Chemistry | 18 | 18 | $13.12 | $236 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohamed Dafalla prescribed most often to Medicare patients was Levothyroxine Sodium, with 200 prescriptions and refills. In total Mohamed Dafalla wrote 1,947 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 200 | 563 | 69 | $2,553 |
| Mounjaro Tirzepatide | 150 | 197 | 35 | $210K |
| Ozempic Semaglutide | 112 | 162 | 28 | $156K |
| Pioglitazone Hcl Generic | 68 | 157 | 24 | $596 |
| Trulicity Dulaglutide | 67 | 92 | 18 | $89K |
| Methimazole Generic | 59 | 143 | 19 | $667 |
| Atorvastatin Calcium Generic | 56 | 173 | 23 | $612 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 53 | 120 | 18 | $70K |
| Novolog Flexpen Insulin Aspart | 46 | 88 | 16 | $11K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 45 | 101 | 15 | $29K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 41 | 104 | 16 | $7,227 |
| Metformin Hcl Er Metformin Hcl | 41 | 123 | 13 | $320 |
| Lisinopril Generic | 37 | 108 | 11 | $362 |
| Glimepiride Generic | 36 | 75 | 12 | $336 |
| Tresiba Flextouch U-100 Insulin Degludec | 34 | 66 | Under 11 | $25K |
Brand drugs: 1,005 claims; generic drugs: 808 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohamed Dafalla $2,898 ($2,898 in general payments such as food, travel and fees) from 29 companies. The largest payer was Medtronic, Inc. with $487.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.